Name: Immunotherapeutic Approaches for Neurological Diseases: Natural Monoclonal Antibodies and Conventional Monoclonal Antibodies (en Inglés)
Price: 676.23 MXN
Availability: InStock
Author: Wootla, Bharath ; Rodriguez, Moses ; Watzlawik, Jens O.
ISBN: 9781922227393

Envío gratis

portada Immunotherapeutic Approaches for Neurological Diseases: Natural Monoclonal Antibodies and Conventional Monoclonal Antibodies (en Inglés)

Formato

Libro Físico

Autor

Editorial

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 0.5 cm

Peso

0.15 kg.

ISBN13

9781922227393

Categorías

Inmunología

Immunotherapeutic Approaches for Neurological Diseases: Natural Monoclonal Antibodies and Conventional Monoclonal Antibodies (en Inglés)

Bharath Wootla (Autor) · Moses Rodriguez (Autor) · Jens O. Watzlawik (Autor) · Iconcept Press · Tapa Blanda

Libro Físico

$ 676.23

$ 1,229.51

Ahorras: $ 553.28

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 17 de Junio y el Martes 25 de Junio.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Immunotherapeutic Approaches for Neurological Diseases: Natural Monoclonal Antibodies and Conventional Monoclonal Antibodies (en Inglés)"

Immunoglobulins with germline sequences occur in invertebrates and vertebrates and are named 'natural antibodies' (NAbs). They may target foreign antigens, self- or altered self-components and are part of the normal immunoglobulin repertoire. NAbs can act as systemic surveillance molecules, which tag damaged or stressed cells, invading pathogens and toxic protein aggregates for elimination by the immune system. Certain NAbs actively signal in different cell types with a broad range of responses from induction of apoptosis in cancer cells, stimulation of remyelination in glial cells and blocking disease propagation in neurodegenerative disorders. This lecture note emphasizes the different functions and characteristics of NAbs and their use as potential therapeutics in multiple sclerosis (MS) as an example for neuroinflammatory diseases. Within neurodegenerative diseases we will focus on Alzheimer's disease as the best investigated disease for immunotherapeutic approaches. We will highlight the role of the blood brain barrier (BBB) as the major obstacle for antibody based therapies of CNS diseases and stress on some novel approaches to lower the hurdle.